0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Vaccine Vial - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: December 2024
|
Report Code: QYRE-Auto-22S7691
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Vaccine Vial Market Insights and Forecast to 2028
BUY CHAPTERS

Vaccine Vial - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-22S7691
Report
December 2024
Pages:142
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Vaccine Vial - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Vaccine Vial - Market

Vaccine Vial - Market

Vaccine bottles are made of special glass, usually containing 2 ml to 100 ml of liquid, with an average height of 45 mm.In addition, vaccine bottles must also be resistant to low temperatures and be able to withstand the wear and tear caused by global transportation.
The global market for Vaccine Vial was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Vaccine Vial, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Vaccine Vial by region & country, by Type, and by Application.
The Vaccine Vial market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Vaccine Vial.
Market Segmentation

Scope of Vaccine Vial - Market Report

Report Metric Details
Report Name Vaccine Vial - Market
CAGR 5%
Segment by Type:
  • by Capacity
  • Single Dose
  • Multi-dose
by Product Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Schott, Nippon Electric Glass, Corning, DWK Life Sciences, Richland Glass, Nipro, Pacific Vial Manufacturing, Origin Ltd, Stevanato Group, SGD Pharma, Piramal Glass, Zheng Chuan, Shandong Pharmaceutical Glass, Gerresheimer, Four Stars Glass, JOTOP Glass
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Vaccine Vial manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Vaccine Vial in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Vaccine Vial in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Vaccine Vial - Market report?

Ans: The main players in the Vaccine Vial - Market are Schott, Nippon Electric Glass, Corning, DWK Life Sciences, Richland Glass, Nipro, Pacific Vial Manufacturing, Origin Ltd, Stevanato Group, SGD Pharma, Piramal Glass, Zheng Chuan, Shandong Pharmaceutical Glass, Gerresheimer, Four Stars Glass, JOTOP Glass

What are the Application segmentation covered in the Vaccine Vial - Market report?

Ans: The Applications covered in the Vaccine Vial - Market report are Preventive Vaccine, Therapeutic Vaccine

What are the Type segmentation covered in the Vaccine Vial - Market report?

Ans: The Types covered in the Vaccine Vial - Market report are Molded Glass Vial, Tubular Glass Vial

Recommended Reports

Vaccine Packaging

Vaccine Delivery

Cold Chain & Storage

1 Market Overview
1.1 Vaccine Vial Product Introduction
1.2 Global Vaccine Vial Market Size Forecast
1.2.1 Global Vaccine Vial Sales Value (2019-2030)
1.2.2 Global Vaccine Vial Sales Volume (2019-2030)
1.2.3 Global Vaccine Vial Sales Price (2019-2030)
1.3 Vaccine Vial Market Trends & Drivers
1.3.1 Vaccine Vial Industry Trends
1.3.2 Vaccine Vial Market Drivers & Opportunity
1.3.3 Vaccine Vial Market Challenges
1.3.4 Vaccine Vial Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Vaccine Vial Players Revenue Ranking (2023)
2.2 Global Vaccine Vial Revenue by Company (2019-2024)
2.3 Global Vaccine Vial Players Sales Volume Ranking (2023)
2.4 Global Vaccine Vial Sales Volume by Company Players (2019-2024)
2.5 Global Vaccine Vial Average Price by Company (2019-2024)
2.6 Key Manufacturers Vaccine Vial Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Vaccine Vial Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Vaccine Vial
2.9 Vaccine Vial Market Competitive Analysis
2.9.1 Vaccine Vial Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Vaccine Vial Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccine Vial as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Single Dose
3.1.2 Multi-dose
3.2 Global Vaccine Vial Sales Value by Type
3.2.1 Global Vaccine Vial Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Vaccine Vial Sales Value, by Type (2019-2030)
3.2.3 Global Vaccine Vial Sales Value, by Type (%) (2019-2030)
3.3 Global Vaccine Vial Sales Volume by Type
3.3.1 Global Vaccine Vial Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Vaccine Vial Sales Volume, by Type (2019-2030)
3.3.3 Global Vaccine Vial Sales Volume, by Type (%) (2019-2030)
3.4 Global Vaccine Vial Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Preventive Vaccine
4.1.2 Therapeutic Vaccine
4.2 Global Vaccine Vial Sales Value by Application
4.2.1 Global Vaccine Vial Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Vaccine Vial Sales Value, by Application (2019-2030)
4.2.3 Global Vaccine Vial Sales Value, by Application (%) (2019-2030)
4.3 Global Vaccine Vial Sales Volume by Application
4.3.1 Global Vaccine Vial Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Vaccine Vial Sales Volume, by Application (2019-2030)
4.3.3 Global Vaccine Vial Sales Volume, by Application (%) (2019-2030)
4.4 Global Vaccine Vial Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Vaccine Vial Sales Value by Region
5.1.1 Global Vaccine Vial Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Vaccine Vial Sales Value by Region (2019-2024)
5.1.3 Global Vaccine Vial Sales Value by Region (2025-2030)
5.1.4 Global Vaccine Vial Sales Value by Region (%), (2019-2030)
5.2 Global Vaccine Vial Sales Volume by Region
5.2.1 Global Vaccine Vial Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Vaccine Vial Sales Volume by Region (2019-2024)
5.2.3 Global Vaccine Vial Sales Volume by Region (2025-2030)
5.2.4 Global Vaccine Vial Sales Volume by Region (%), (2019-2030)
5.3 Global Vaccine Vial Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Vaccine Vial Sales Value, 2019-2030
5.4.2 North America Vaccine Vial Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Vaccine Vial Sales Value, 2019-2030
5.5.2 Europe Vaccine Vial Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Vaccine Vial Sales Value, 2019-2030
5.6.2 Asia Pacific Vaccine Vial Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Vaccine Vial Sales Value, 2019-2030
5.7.2 South America Vaccine Vial Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Vaccine Vial Sales Value, 2019-2030
5.8.2 Middle East & Africa Vaccine Vial Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Vaccine Vial Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Vaccine Vial Sales Value
6.2.1 Key Countries/Regions Vaccine Vial Sales Value, 2019-2030
6.2.2 Key Countries/Regions Vaccine Vial Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Vaccine Vial Sales Value, 2019-2030
6.3.2 United States Vaccine Vial Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Vaccine Vial Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Vaccine Vial Sales Value, 2019-2030
6.4.2 Europe Vaccine Vial Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Vaccine Vial Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Vaccine Vial Sales Value, 2019-2030
6.5.2 China Vaccine Vial Sales Value by Type (%), 2023 VS 2030
6.5.3 China Vaccine Vial Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Vaccine Vial Sales Value, 2019-2030
6.6.2 Japan Vaccine Vial Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Vaccine Vial Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Vaccine Vial Sales Value, 2019-2030
6.7.2 South Korea Vaccine Vial Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Vaccine Vial Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Vaccine Vial Sales Value, 2019-2030
6.8.2 Southeast Asia Vaccine Vial Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Vaccine Vial Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Vaccine Vial Sales Value, 2019-2030
6.9.2 India Vaccine Vial Sales Value by Type (%), 2023 VS 2030
6.9.3 India Vaccine Vial Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Schott
7.1.1 Schott Company Information
7.1.2 Schott Introduction and Business Overview
7.1.3 Schott Vaccine Vial Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Schott Vaccine Vial Product Offerings
7.1.5 Schott Recent Development
7.2 Nippon Electric Glass
7.2.1 Nippon Electric Glass Company Information
7.2.2 Nippon Electric Glass Introduction and Business Overview
7.2.3 Nippon Electric Glass Vaccine Vial Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Nippon Electric Glass Vaccine Vial Product Offerings
7.2.5 Nippon Electric Glass Recent Development
7.3 Corning
7.3.1 Corning Company Information
7.3.2 Corning Introduction and Business Overview
7.3.3 Corning Vaccine Vial Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Corning Vaccine Vial Product Offerings
7.3.5 Corning Recent Development
7.4 DWK Life Sciences
7.4.1 DWK Life Sciences Company Information
7.4.2 DWK Life Sciences Introduction and Business Overview
7.4.3 DWK Life Sciences Vaccine Vial Sales, Revenue and Gross Margin (2019-2024)
7.4.4 DWK Life Sciences Vaccine Vial Product Offerings
7.4.5 DWK Life Sciences Recent Development
7.5 Richland Glass
7.5.1 Richland Glass Company Information
7.5.2 Richland Glass Introduction and Business Overview
7.5.3 Richland Glass Vaccine Vial Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Richland Glass Vaccine Vial Product Offerings
7.5.5 Richland Glass Recent Development
7.6 Nipro
7.6.1 Nipro Company Information
7.6.2 Nipro Introduction and Business Overview
7.6.3 Nipro Vaccine Vial Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Nipro Vaccine Vial Product Offerings
7.6.5 Nipro Recent Development
7.7 Pacific Vial Manufacturing
7.7.1 Pacific Vial Manufacturing Company Information
7.7.2 Pacific Vial Manufacturing Introduction and Business Overview
7.7.3 Pacific Vial Manufacturing Vaccine Vial Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Pacific Vial Manufacturing Vaccine Vial Product Offerings
7.7.5 Pacific Vial Manufacturing Recent Development
7.8 Origin Ltd
7.8.1 Origin Ltd Company Information
7.8.2 Origin Ltd Introduction and Business Overview
7.8.3 Origin Ltd Vaccine Vial Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Origin Ltd Vaccine Vial Product Offerings
7.8.5 Origin Ltd Recent Development
7.9 Stevanato Group
7.9.1 Stevanato Group Company Information
7.9.2 Stevanato Group Introduction and Business Overview
7.9.3 Stevanato Group Vaccine Vial Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Stevanato Group Vaccine Vial Product Offerings
7.9.5 Stevanato Group Recent Development
7.10 SGD Pharma
7.10.1 SGD Pharma Company Information
7.10.2 SGD Pharma Introduction and Business Overview
7.10.3 SGD Pharma Vaccine Vial Sales, Revenue and Gross Margin (2019-2024)
7.10.4 SGD Pharma Vaccine Vial Product Offerings
7.10.5 SGD Pharma Recent Development
7.11 Piramal Glass
7.11.1 Piramal Glass Company Information
7.11.2 Piramal Glass Introduction and Business Overview
7.11.3 Piramal Glass Vaccine Vial Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Piramal Glass Vaccine Vial Product Offerings
7.11.5 Piramal Glass Recent Development
7.12 Zheng Chuan
7.12.1 Zheng Chuan Company Information
7.12.2 Zheng Chuan Introduction and Business Overview
7.12.3 Zheng Chuan Vaccine Vial Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Zheng Chuan Vaccine Vial Product Offerings
7.12.5 Zheng Chuan Recent Development
7.13 Shandong Pharmaceutical Glass
7.13.1 Shandong Pharmaceutical Glass Company Information
7.13.2 Shandong Pharmaceutical Glass Introduction and Business Overview
7.13.3 Shandong Pharmaceutical Glass Vaccine Vial Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Shandong Pharmaceutical Glass Vaccine Vial Product Offerings
7.13.5 Shandong Pharmaceutical Glass Recent Development
7.14 Gerresheimer
7.14.1 Gerresheimer Company Information
7.14.2 Gerresheimer Introduction and Business Overview
7.14.3 Gerresheimer Vaccine Vial Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Gerresheimer Vaccine Vial Product Offerings
7.14.5 Gerresheimer Recent Development
7.15 Four Stars Glass
7.15.1 Four Stars Glass Company Information
7.15.2 Four Stars Glass Introduction and Business Overview
7.15.3 Four Stars Glass Vaccine Vial Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Four Stars Glass Vaccine Vial Product Offerings
7.15.5 Four Stars Glass Recent Development
7.16 JOTOP Glass
7.16.1 JOTOP Glass Company Information
7.16.2 JOTOP Glass Introduction and Business Overview
7.16.3 JOTOP Glass Vaccine Vial Sales, Revenue and Gross Margin (2019-2024)
7.16.4 JOTOP Glass Vaccine Vial Product Offerings
7.16.5 JOTOP Glass Recent Development
8 Industry Chain Analysis
8.1 Vaccine Vial Industrial Chain
8.2 Vaccine Vial Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Vaccine Vial Sales Model
8.5.2 Sales Channel
8.5.3 Vaccine Vial Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Vaccine Vial Market Trends
    Table 2. Vaccine Vial Market Drivers & Opportunity
    Table 3. Vaccine Vial Market Challenges
    Table 4. Vaccine Vial Market Restraints
    Table 5. Global Vaccine Vial Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Vaccine Vial Revenue Market Share by Company (2019-2024)
    Table 7. Global Vaccine Vial Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Vaccine Vial Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Vaccine Vial Price by Company (2019-2024) & (US$/K Units)
    Table 10. Key Manufacturers Vaccine Vial Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Vaccine Vial Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Vaccine Vial
    Table 13. Global Vaccine Vial Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccine Vial as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Vaccine Vial Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Vaccine Vial Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Vaccine Vial Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Vaccine Vial Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Vaccine Vial Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Vaccine Vial Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Vaccine Vial Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Vaccine Vial Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Vaccine Vial Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Vaccine Vial Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Vaccine Vial Price by Type (2019-2024) & (US$/K Units)
    Table 27. Global Vaccine Vial Price by Type (2025-2030) & (US$/K Units)
    Table 28. Global Vaccine Vial Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Vaccine Vial Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Vaccine Vial Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Vaccine Vial Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Vaccine Vial Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Vaccine Vial Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Vaccine Vial Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Vaccine Vial Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Vaccine Vial Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Vaccine Vial Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Vaccine Vial Price by Application (2019-2024) & (US$/K Units)
    Table 39. Global Vaccine Vial Price by Application (2025-2030) & (US$/K Units)
    Table 40. Global Vaccine Vial Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Vaccine Vial Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Vaccine Vial Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Vaccine Vial Sales Value by Region (2019-2024) & (%)
    Table 44. Global Vaccine Vial Sales Value by Region (2025-2030) & (%)
    Table 45. Global Vaccine Vial Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Vaccine Vial Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Vaccine Vial Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Vaccine Vial Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Vaccine Vial Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Vaccine Vial Average Price by Region (2019-2024) & (US$/K Units)
    Table 51. Global Vaccine Vial Average Price by Region (2025-2030) & (US$/K Units)
    Table 52. Key Countries/Regions Vaccine Vial Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Vaccine Vial Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Vaccine Vial Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Vaccine Vial Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Vaccine Vial Sales Volume, (2025-2030) & (K Units)
    Table 57. Schott Company Information
    Table 58. Schott Introduction and Business Overview
    Table 59. Schott Vaccine Vial Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
    Table 60. Schott Vaccine Vial Product Offerings
    Table 61. Schott Recent Development
    Table 62. Nippon Electric Glass Company Information
    Table 63. Nippon Electric Glass Introduction and Business Overview
    Table 64. Nippon Electric Glass Vaccine Vial Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
    Table 65. Nippon Electric Glass Vaccine Vial Product Offerings
    Table 66. Nippon Electric Glass Recent Development
    Table 67. Corning Company Information
    Table 68. Corning Introduction and Business Overview
    Table 69. Corning Vaccine Vial Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
    Table 70. Corning Vaccine Vial Product Offerings
    Table 71. Corning Recent Development
    Table 72. DWK Life Sciences Company Information
    Table 73. DWK Life Sciences Introduction and Business Overview
    Table 74. DWK Life Sciences Vaccine Vial Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
    Table 75. DWK Life Sciences Vaccine Vial Product Offerings
    Table 76. DWK Life Sciences Recent Development
    Table 77. Richland Glass Company Information
    Table 78. Richland Glass Introduction and Business Overview
    Table 79. Richland Glass Vaccine Vial Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
    Table 80. Richland Glass Vaccine Vial Product Offerings
    Table 81. Richland Glass Recent Development
    Table 82. Nipro Company Information
    Table 83. Nipro Introduction and Business Overview
    Table 84. Nipro Vaccine Vial Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
    Table 85. Nipro Vaccine Vial Product Offerings
    Table 86. Nipro Recent Development
    Table 87. Pacific Vial Manufacturing Company Information
    Table 88. Pacific Vial Manufacturing Introduction and Business Overview
    Table 89. Pacific Vial Manufacturing Vaccine Vial Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
    Table 90. Pacific Vial Manufacturing Vaccine Vial Product Offerings
    Table 91. Pacific Vial Manufacturing Recent Development
    Table 92. Origin Ltd Company Information
    Table 93. Origin Ltd Introduction and Business Overview
    Table 94. Origin Ltd Vaccine Vial Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
    Table 95. Origin Ltd Vaccine Vial Product Offerings
    Table 96. Origin Ltd Recent Development
    Table 97. Stevanato Group Company Information
    Table 98. Stevanato Group Introduction and Business Overview
    Table 99. Stevanato Group Vaccine Vial Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
    Table 100. Stevanato Group Vaccine Vial Product Offerings
    Table 101. Stevanato Group Recent Development
    Table 102. SGD Pharma Company Information
    Table 103. SGD Pharma Introduction and Business Overview
    Table 104. SGD Pharma Vaccine Vial Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
    Table 105. SGD Pharma Vaccine Vial Product Offerings
    Table 106. SGD Pharma Recent Development
    Table 107. Piramal Glass Company Information
    Table 108. Piramal Glass Introduction and Business Overview
    Table 109. Piramal Glass Vaccine Vial Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
    Table 110. Piramal Glass Vaccine Vial Product Offerings
    Table 111. Piramal Glass Recent Development
    Table 112. Zheng Chuan Company Information
    Table 113. Zheng Chuan Introduction and Business Overview
    Table 114. Zheng Chuan Vaccine Vial Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
    Table 115. Zheng Chuan Vaccine Vial Product Offerings
    Table 116. Zheng Chuan Recent Development
    Table 117. Shandong Pharmaceutical Glass Company Information
    Table 118. Shandong Pharmaceutical Glass Introduction and Business Overview
    Table 119. Shandong Pharmaceutical Glass Vaccine Vial Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
    Table 120. Shandong Pharmaceutical Glass Vaccine Vial Product Offerings
    Table 121. Shandong Pharmaceutical Glass Recent Development
    Table 122. Gerresheimer Company Information
    Table 123. Gerresheimer Introduction and Business Overview
    Table 124. Gerresheimer Vaccine Vial Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
    Table 125. Gerresheimer Vaccine Vial Product Offerings
    Table 126. Gerresheimer Recent Development
    Table 127. Four Stars Glass Company Information
    Table 128. Four Stars Glass Introduction and Business Overview
    Table 129. Four Stars Glass Vaccine Vial Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
    Table 130. Four Stars Glass Vaccine Vial Product Offerings
    Table 131. Four Stars Glass Recent Development
    Table 132. JOTOP Glass Company Information
    Table 133. JOTOP Glass Introduction and Business Overview
    Table 134. JOTOP Glass Vaccine Vial Sales (K Units), Revenue (US$ Million), Price (US$/K Units) and Gross Margin (2019-2024)
    Table 135. JOTOP Glass Vaccine Vial Product Offerings
    Table 136. JOTOP Glass Recent Development
    Table 137. Key Raw Materials Lists
    Table 138. Raw Materials Key Suppliers Lists
    Table 139. Vaccine Vial Downstream Customers
    Table 140. Vaccine Vial Distributors List
    Table 141. Research Programs/Design for This Report
    Table 142. Key Data Information from Secondary Sources
    Table 143. Key Data Information from Primary Sources
List of Figures
    Figure 1. Vaccine Vial Product Picture
    Figure 2. Global Vaccine Vial Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Vaccine Vial Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Vaccine Vial Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Vaccine Vial Sales Price (2019-2030) & (US$/K Units)
    Figure 6. Vaccine Vial Report Years Considered
    Figure 7. Global Vaccine Vial Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Vaccine Vial Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Vaccine Vial Revenue in 2023
    Figure 10. Vaccine Vial Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Single Dose Picture
    Figure 12. Multi-dose Picture
    Figure 13. Global Vaccine Vial Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Vaccine Vial Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global Vaccine Vial Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 16. Global Vaccine Vial Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global Vaccine Vial Price by Type (2019-2030) & (US$/K Units)
    Figure 18. Product Picture of Preventive Vaccine
    Figure 19. Product Picture of Therapeutic Vaccine
    Figure 20. Global Vaccine Vial Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 21. Global Vaccine Vial Sales Value Market Share by Application, 2023 & 2030
    Figure 22. Global Vaccine Vial Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 23. Global Vaccine Vial Sales Volume Market Share by Application, 2023 & 2030
    Figure 24. Global Vaccine Vial Price by Application (2019-2030) & (US$/K Units)
    Figure 25. North America Vaccine Vial Sales Value (2019-2030) & (US$ Million)
    Figure 26. North America Vaccine Vial Sales Value by Country (%), 2023 VS 2030
    Figure 27. Europe Vaccine Vial Sales Value (2019-2030) & (US$ Million)
    Figure 28. Europe Vaccine Vial Sales Value by Country (%), 2023 VS 2030
    Figure 29. Asia Pacific Vaccine Vial Sales Value (2019-2030) & (US$ Million)
    Figure 30. Asia Pacific Vaccine Vial Sales Value by Country (%), 2023 VS 2030
    Figure 31. South America Vaccine Vial Sales Value (2019-2030) & (US$ Million)
    Figure 32. South America Vaccine Vial Sales Value by Country (%), 2023 VS 2030
    Figure 33. Middle East & Africa Vaccine Vial Sales Value (2019-2030) & (US$ Million)
    Figure 34. Middle East & Africa Vaccine Vial Sales Value by Country (%), 2023 VS 2030
    Figure 35. Key Countries/Regions Vaccine Vial Sales Value (%), (2019-2030)
    Figure 36. Key Countries/Regions Vaccine Vial Sales Volume (%), (2019-2030)
    Figure 37. United States Vaccine Vial Sales Value, (2019-2030) & (US$ Million)
    Figure 38. United States Vaccine Vial Sales Value by Type (%), 2023 VS 2030
    Figure 39. United States Vaccine Vial Sales Value by Application (%), 2023 VS 2030
    Figure 40. Europe Vaccine Vial Sales Value, (2019-2030) & (US$ Million)
    Figure 41. Europe Vaccine Vial Sales Value by Type (%), 2023 VS 2030
    Figure 42. Europe Vaccine Vial Sales Value by Application (%), 2023 VS 2030
    Figure 43. China Vaccine Vial Sales Value, (2019-2030) & (US$ Million)
    Figure 44. China Vaccine Vial Sales Value by Type (%), 2023 VS 2030
    Figure 45. China Vaccine Vial Sales Value by Application (%), 2023 VS 2030
    Figure 46. Japan Vaccine Vial Sales Value, (2019-2030) & (US$ Million)
    Figure 47. Japan Vaccine Vial Sales Value by Type (%), 2023 VS 2030
    Figure 48. Japan Vaccine Vial Sales Value by Application (%), 2023 VS 2030
    Figure 49. South Korea Vaccine Vial Sales Value, (2019-2030) & (US$ Million)
    Figure 50. South Korea Vaccine Vial Sales Value by Type (%), 2023 VS 2030
    Figure 51. South Korea Vaccine Vial Sales Value by Application (%), 2023 VS 2030
    Figure 52. Southeast Asia Vaccine Vial Sales Value, (2019-2030) & (US$ Million)
    Figure 53. Southeast Asia Vaccine Vial Sales Value by Type (%), 2023 VS 2030
    Figure 54. Southeast Asia Vaccine Vial Sales Value by Application (%), 2023 VS 2030
    Figure 55. India Vaccine Vial Sales Value, (2019-2030) & (US$ Million)
    Figure 56. India Vaccine Vial Sales Value by Type (%), 2023 VS 2030
    Figure 57. India Vaccine Vial Sales Value by Application (%), 2023 VS 2030
    Figure 58. Vaccine Vial Industrial Chain
    Figure 59. Vaccine Vial Manufacturing Cost Structure
    Figure 60. Channels of Distribution (Direct Sales, and Distribution)
    Figure 61. Bottom-up and Top-down Approaches for This Report
    Figure 62. Data Triangulation
    Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS